Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nature Biotechnology
|
September 10, 2013
Locus-specific editing of histone modifications at endogenous enhancers
Eric M Mendenhall, Kaylyn E Williamson, Deepak Reyon, et al.
Nature Structural & Molecular Biology
|
December 19, 2022
A pioneer factor locally opens compacted chromatin to enable targeted ATP-dependent nucleosome remodeling
Megan A Frederick, Kaylyn E Williamson, Meilin Fernandez Garcia, et al.
Cancer Research
|
February 4, 2016
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes
John P McGrath, Kaylyn E Williamson, Srividya Balasubramanian, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Siddhant U Jain, Kaylyn E Williamson, Alexander W Ying, et al.
Cell Chemical Biology
|
May 28, 2026
Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinoma
Jacob I Stuckey, Jennifer A Mertz, Jonathan E Wilson, et al.
Molecular Cell
|
August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis
Gabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Nature Genetics
|
February 2, 2016
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier, Matthew J Cotton, Kaylyn E Williamson, et al.
Science (New York, N.Y.)
|
January 1, 2026
A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Siddhant U Jain, Kaylyn E Williamson, Alexander W Ying, et al.
Chemistry & Biology
|
December 3, 2014
EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation
William D Bradley, Shilpi Arora, Jennifer Busby, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nature Biotechnology
|
September 10, 2013
Locus-specific editing of histone modifications at endogenous enhancers
Eric M Mendenhall, Kaylyn E Williamson, Deepak Reyon, et al.
Nature Structural & Molecular Biology
|
December 19, 2022
A pioneer factor locally opens compacted chromatin to enable targeted ATP-dependent nucleosome remodeling
Megan A Frederick, Kaylyn E Williamson, Meilin Fernandez Garcia, et al.
Cancer Research
|
February 4, 2016
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes
John P McGrath, Kaylyn E Williamson, Srividya Balasubramanian, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Siddhant U Jain, Kaylyn E Williamson, Alexander W Ying, et al.
Cell Chemical Biology
|
May 28, 2026
Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinoma
Jacob I Stuckey, Jennifer A Mertz, Jonathan E Wilson, et al.
Molecular Cell
|
August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis
Gabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Nature Genetics
|
February 2, 2016
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier, Matthew J Cotton, Kaylyn E Williamson, et al.
Science (New York, N.Y.)
|
January 1, 2026
A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Siddhant U Jain, Kaylyn E Williamson, Alexander W Ying, et al.
Chemistry & Biology
|
December 3, 2014
EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation
William D Bradley, Shilpi Arora, Jennifer Busby, et al.
Page
of 2